Sign inGet started

Davis Hugh M.

Insider CIK 2045027 · ACRS President and COO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACRS Aclaris Therapeutics, Inc. M Exercise deriv2026-02-032026-02-0518,675— $056,025SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise2026-02-032026-02-0518,675— $045,425SEC↗
ACRS Aclaris Therapeutics, Inc. A Award deriv2026-02-022026-02-06336,300— $0336,300SEC↗
ACRS Aclaris Therapeutics, Inc. A Award deriv2026-02-022026-02-0696,100— $096,100SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise deriv2025-12-022025-12-0426,750— $080,250SEC↗
ACRS Aclaris Therapeutics, Inc. M Exercise2025-12-022025-12-0426,750— $026,750SEC↗
ACRS Aclaris Therapeutics, Inc. A Award deriv2025-02-032025-02-0474,700— $074,700SEC↗
ACRS Aclaris Therapeutics, Inc. A Award deriv2025-02-032025-02-04261,600— $0261,600SEC↗
ACRS Aclaris Therapeutics, Inc. A Award deriv2024-12-022024-12-03375,000— $0375,000SEC↗
ACRS Aclaris Therapeutics, Inc. A Award deriv2024-12-022024-12-03107,000— $0107,000SEC↗